Hikal reported bad set of numbers.
However,management commentary in Q1FY26 was alluding to the fact that recovery will happen from H2FY26.
same commentary has been highlighted in Q2FY26 press release.
https://www.bseindia.com/xml-data/corpfiling/AttachLive/66ab4388-389a-4085-8f56-600cc6246fe0.pdf
Debt also coming down
Disc: Invested. No transactions in last 30 days.
Good results from Hikal. As promised by the Management, recovery has started from Q3 and expected to be continued in Q4 FY26 also.
ICICI PHD fund name appearing in Dec SHP.
Disc: Added in the recent fall.
Gold medal Award:
Good management interview
Management walking the talk slowly. Completely ignored CDMO counter. Maybe due to past bad track record of the management and capital misallocation or poor returns in agrochemical division.
disc: biased due to my holding. No transactions in the last 3 months.
cc: @Sridharj
Mgt guided for 14 to 16 percent topline growth for fy27 and 30% growth for EBITDA let us c if they achieve it
Disclosure: Holding